S I Martin

Summary

Affiliation: The Ohio State University
Country: USA

Publications

  1. ncbi Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days
    Stanley I Martin
    Division of Infectious Diseases, The Ohio State University Medical Center, N1148 Doan Hall, 410 West 10th Ave, Columbus, OH 43210, USA
    Interact Cardiovasc Thorac Surg 11:20-3. 2010
  2. ncbi Ceftaroline fosamil: a novel broad-spectrum cephalosporin
    J A Bazan
    Division of Infectious Diseases, The Ohio State University Medical Center, Columbus, Ohio, USA
    Drugs Today (Barc) 46:743-55. 2010
  3. ncbi Monitoring infection with Epstein-Barr virus among seromismatch adult renal transplant recipients
    S I Martin
    Division of Infectious Diseases and The Comprehensive Transplant Center, The Ohio State University Medical Center, Columbus, OH, USA
    Am J Transplant 11:1058-63. 2011

Detail Information

Publications3

  1. ncbi Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days
    Stanley I Martin
    Division of Infectious Diseases, The Ohio State University Medical Center, N1148 Doan Hall, 410 West 10th Ave, Columbus, OH 43210, USA
    Interact Cardiovasc Thorac Surg 11:20-3. 2010
    ..BMI, including morbid obesity, does not appear to be a statistically significant relevant factor in determining that risk. Device type may have an effect, however, on risk of infection in long-term support...
  2. ncbi Ceftaroline fosamil: a novel broad-spectrum cephalosporin
    J A Bazan
    Division of Infectious Diseases, The Ohio State University Medical Center, Columbus, Ohio, USA
    Drugs Today (Barc) 46:743-55. 2010
    ..Ceftaroline fosamil is still under review by the U.S. FDA, and when approved, will be one of the first commercially available ?-lactams with the ability to treat infections due to MRSA and other drug-resistant Gram-positive pathogens...
  3. ncbi Monitoring infection with Epstein-Barr virus among seromismatch adult renal transplant recipients
    S I Martin
    Division of Infectious Diseases and The Comprehensive Transplant Center, The Ohio State University Medical Center, Columbus, OH, USA
    Am J Transplant 11:1058-63. 2011
    ..Use of rituximab in preventing PTLD among patients with primary EBV infection requires further prospective study to determine its overall safety and efficacy...